Beijing Chunlizhengda Medical Instruments Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
327.00
142.00
338.00
391.00
442.00
370.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
65.00
-197.00
216.00
-343.00
-235.00
-41.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
455.00
20.00
590.00
79.00
209.00
295.00
Cash Flow from Investing Activities
-138.00
38.00
-114.00
-918.00
-240.00
-26.00
Cash Flow from Financing Activities
-32.00
-198.00
-134.00
-68.00
1,293.00
-13.00
Net Cash Inflow / Outflow
285.00
-137.00
341.00
-906.00
1,261.00
253.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
0.00
1.00
-2.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Beijing Chunlizhengda Medical Instruments Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
327.213404609126
249.103680486919
78.00
31.36%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
65.9469883474977
51.1395859794061
14.00
28.95%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
455.986866408036
399.751162283696
56.00
14.07%
Cash Flow from Investing Activities
-138.065219891819
-76.9419449833264
-62.00
-79.44%
Cash Flow from Financing Activities
-32.0091002032311
-228.001431840255
196.00
85.96%
Net Cash Inflow / Outflow
285.722927118944
100.104218930748
185.00
185.43%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.189619194041449
5.29643347063411
-5.00
-103.58%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 2,144.56% vs -96.56% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
455.99
20.32
2,144.56%






